Skip to content

QuarterlyIQ Insights · ISRG

Factors

The full factor breakdown (the numbers behind each rank). The overview page shows the same reads in short form; this is the depth.

Factor signals

Each factor is a parallel diagnostic with a plain-language read of what it shows and how names like it have historically fared. Never aggregated into a single score.

Recent financial performance
strong

Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated strong grew net income 59% of the time over the next year (vs 52% for the rest of the cohort, n=2344).

79th pctl · Health Care
The numbers
bonus
0
dir share
1
slope norm
0.0546
Earnings quality
fragile

Over the trailing year it converted 1.13x of net income into operating cash flow. Historically, Health Care names rated fragile grew net income 40% of the time over the next year (vs 56% for the rest of the cohort, n=1703).

19th pctl · Health Care
The numbers
ttm ni
2979.1
ttm cfo
3360.8
Macro sensitivity

Most sensitive to the broad stock market.

  • the broad stock market: This stock moves with the broad market (high beta).β 1.16 · R² 0.37

Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates (low R² over the window).

Management & capital allocation
neutral

5 material management or governance events in the past 24 months, led by executive changes. Historically, Health Care names rated neutral grew net income 58% of the time over the next year (vs 50% for the rest of the cohort, n=842).

35th pctl · Health Care
The numbers
n events
5
raw activity
0.9485
directional rank
0.8798
directional status
capital_friendly

Not investment advice. As of 2026-06-09.

Earnings setup & market context

The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.

Earnings setup · pre-print positioning
forward-looking
bullish strong24 analysts, 67% Buyfor period ending 2026-06-30
Why this setup
Consensus revisions

EPS estimate $2.50 → $2.50 (-0.0% / 30d). 1 raised, 0 cut, 24 covering analysts.

Rating actions

0 upgrades, 0 downgrades / 30d, 1 maintained. 67% of analysts rate Buy.

Price target activity

2 PT revisions / 30d. Avg target 36.8% above current price.

Material events

0 positive, 0 negative / 30d.

Market and fundamentals agree. Analysts are positioned bullishly on a fundamentally strong name.

Sector context
Intermediate · Weekly
Sector phase: health care is in growth, with decelerating (~2.5 years in phase).
Sector regime (90d momentum): headwind.
headwind-9.2%sector vs S&P 500, 60d

via XLV

Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.

Full health care context →All sectors →

AI cycle regime · market-wide
2-axis classifierLong-term · 1–3 yr
HeatingManiaSquallCrisisEarnings →Mood ↑
HeatingE -0.23 · M +0.31
Single-axisneutralz +0.26

Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.

Not investment advice. As of 2026-06-09.